NuCana (NCNA) Research & Development (2017 - 2025)
NuCana (NCNA) reported Research & Development of -$2.3 million for Q4 2025, down 146.79% on a YoY basis from $4.9 million in Q4 2024, and up 21.21% sequentially from -$2.9 million in Q3 2025.
NuCana (NCNA) Research & Development (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Research & Development data on file, last reported at -$2.3 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 146.79% year-over-year to -$2.3 million; the trailing twelve-month figure through Dec 2025 stood at -$16.9 million (up 26.37% YoY), and the FY2025 full-year result was -$16.8 million, up 27.08% from the prior year.
- Research & Development grew to -$2.3 million in Q4 2025, from -$2.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.9 million in Q2 2021 to a low of -$15.5 million in Q4 2022.
- A 5-year average of -$6.3 million and a median of -$8.5 million in 2023 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 263.64% in 2021, while the deepest fall reached 257.72% in 2021.
- Tracing NCNA's Research & Development over 5 years: stood at -$14.3 million in 2021, then declined by 7.91% to -$15.5 million in 2022, then surged by 44.97% to -$8.5 million in 2023, then soared by 89.01% to -$935672.8 in 2024, then plunged by 146.79% to -$2.3 million in 2025.
- Business Quant data shows NCNA's Research & Development at -$2.3 million in Q4 2025, -$2.9 million in Q3 2025, and -$9.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | -2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -9.48 Mn |
| Mar 31, 2025 | -2.17 Mn |
| Dec 31, 2024 | -935,672.84 |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -8.54 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Dec 31, 2023 | -8.51 Mn |
| Sep 30, 2023 | -9.42 Mn |
| Jun 30, 2023 | -4.95 Mn |
| Mar 31, 2023 | -8.27 Mn |
| Dec 31, 2022 | -15.47 Mn |
| Sep 30, 2022 | -8.70 Mn |
| Jun 30, 2022 | 8.07 Mn |
| Mar 31, 2022 | -12.67 Mn |
| Dec 31, 2021 | -14.33 Mn |
| Sep 30, 2021 | -12.37 Mn |
| Jun 30, 2021 | 11.91 Mn |
| Mar 31, 2021 | -12.00 Mn |